Advancing chemical mixture toxicity assessment using advanced in vitro NAMs: current status and future perspectives
Kim H., Kim D., Choi J.
Narrative Review, published in Front Toxicol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Toxicol (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42293281
- PMCID
- PMC13258531
- DOI
- 10.3389/ftox.2026.1757928
Abstract (original English)
Chemical exposure in real-world settings occurs predominantly as mixtures, whereas toxicological assessment has long been shaped by single-substance paradigms. As interest in more human-relevant and mechanistically informative testing strategies has grown, new approach methodologies (NAMs) have been increasingly incorporated into mixture toxicity research. However, the role of advanced in vitro NAMs in chemical mixture toxicity assessment has not yet been examined in a structured manner. This review therefore evaluated how advanced in vitro NAMs are currently being applied in mixture toxicity assessment and considered their potential value for regulatory translation. A PubMed-based literature search covering studies published between 2021 and 2025 identified 353 in vitro NAM-based studies related to chemical mixture toxicity, of which 70 were classified as advanced in vitro NAM-based studies and included for in-depth analysis. Among the advanced in vitro NAM categories, route-of-exposure-relevant models were the most frequently applied, followed by Omics, 3D models, stem cell-based models, and HTS/HCI approaches. The reviewed studies addressed diverse mixtures, including air pollutants, PFAS, phthalates, pesticides/herbicides, consumer product-related mixtures, and other environmentally relevant chemical combinations. Across these studies, advanced in vitro NAMs were used not o
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.